Impact of Prior Tuberculosis Treatment With New/Companion Drugs on Clinical Outcomes in Patients Receiving Concomitant Bedaquiline and Delamanid for …
L Mikiashvili, RR Kempker, TS Chakhaia… - Clinical Infectious …, 2024 - academic.oup.com
Background There are scarce data on the clinical outcomes of persons retreated with
new/companion anti-tuberculosis (TB) drugs for multidrug-and rifampicin-resistant …
new/companion anti-tuberculosis (TB) drugs for multidrug-and rifampicin-resistant …
Numerous Asymptomatic Brain Tuberculomas Complicated by Fatal Tuberculous Meningitis
I Alavidze, M Shubitidze, G Khodeli, S Dvali… - Cureus, 2024 - pmc.ncbi.nlm.nih.gov
Tuberculosis (TB) is still one of the most challenging infectious diseases worldwide.
Coinfection with HIV increases the likelihood of extrapulmonary involvement, including the …
Coinfection with HIV increases the likelihood of extrapulmonary involvement, including the …